This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reimer, K. A. Articles by Jennings, R. B. Search for Related Content PubMed PubMed Citation Articles by Reimer, K. A. Articles by Jennings, R. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL VERAPAMIL HYDROCHLORIDE

Circulation, Vol 55, 581-587, Copyright © 1977 by American Heart Association

ARTICLES

Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs

KA Reimer, JE Lowe and RB Jennings

Calcium metabolism may play an important role in the pathogenesis of myocardial ischemic injury. The effect of the sarcolemmal calcium flux inhibitor, verapamil, on myocardial necrosis was studied in dogs subjected to temporary coronary artery occlusion. One group of dogs was untreated. A second group was given 0.8 mg/kg verapamil intravenously over a 30 min period beginning 10 min prior to coronary occlusion. In a third group, the dose of verapamil was increased until complicated by hypotension or conduction abnormalities. Cardiac necrosis was produced in all dogs by 40 min of left circumflex coronary artery occlusion followed by 2--4 days of reperfusion. At the end of the experiment, animals were sacrificed and necrosis was quantitated histologically in transmural slices through the posterior papillary muscle. Pre-treatment with the lower dose of verapamil resulted in significantly less necrosis (14% treated vs 35% untreated) with minimal hemodynamic consequences. Higher does of verapamil were even more effective in limiting cardiac necrosis despite the development of hypotension and varying degrees of heart block.

This article has been cited by other articles:

				H.-L. Pan, S.-R. Chen, G. M. Scicli, and O. A. Carretero Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H116 - H121. [Abstract] [Full Text] [PDF]

				R. Schulz, H. Post, A. Jalowy, U. Backenkohler, H. Dorge, C. Vahlhaus, and G. Heusch Unique Cardioprotective Action of the New Calcium Antagonist Mibefradil Circulation, January 19, 1999; 99(2): 305 - 311. [Abstract] [Full Text] [PDF]

				E. Patterson, L. Ma, B. Szabo, C. P. Robinson, and U. Thadani Ovariectomy and Estrogen-Induced Alterations in Myocardial Contractility in Female Rabbits: Role of the L-Type Calcium Channel J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 586 - 591. [Abstract] [Full Text]

				H. Miyawaki, X. Zhou, and M. Ashraf Calcium Preconditioning Elicits Strong Protection Against Ischemic Injury via Protein Kinase C Signaling Pathway Circ. Res., July 1, 1996; 79(1): 137 - 146. [Abstract] [Full Text]